Document is current

Article History

Received: 15 October 2025

Revised: 29 December 2025

Accepted: 22 February 2026

First Online: 16 June 2026

Compliance with ethical standards

:

: The scientific guarantor of this publication is Julia Camps-Herrero, MD, at Ribera Salud Hospital. Email: jcamps@riberasalud.es.

: The authors of this manuscript declare relationships with the following companies: Julia Camps-Herrero: Consultant role and honoraria for lectures to Bayer Healthcare, Siemens Healthcare, Hologic, and Becton Dickinson. Alexandra Athanasiou: Honoraria for lectures to the European Society of Breast Imaging. Michael Fuchsjaeger: Consultant role for Bracco, honoraria for lectures to the European Society of Breast Imaging, European Society of Radiology, Siemens Healthcare, and Becton Dickinson. Cristian Kuhl: Consultant role for Bayer Healthcare and Guerbet. Ritse Mann: Grants for research projects, payments to institution from the Dutch Research Council, European Research Council, Horizon Europe, EFRO/OP-Oost, Dutch Cancer Society, InHolland, Siemens Healthineers, Becton Dickinson, Bayer Healthcare, Screenpoint Medical, and Guebert. R.M. is a member of the Advisory Editorial Board of European Radiology (European Society of Breast Imaging) and, as such, did not participate in the selection or review processes for this article. Cristina Saura: Consultant role for AstraZeneca, Daiichi Sankyo, Eisai, MediTech, Novartis, Pfizer, Phillips Healthcare, Pierre Fabre, Puma Biotechnology, Roche, Seagen, Gilead Sciences, Lilly, Synthon, Zymeworks, Pharmalex. Katja Pinker: Consultant role for Genentech, Merantix Healthcare, AURA Health Technologies GmbH, Guerbet, Neodynamics, and Bayer.

: No complex statistical methods were necessary for this paper.

: Not applicable.

: Not applicable.

: Not applicable.

: